Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     

  • OIL

    83.24
    +0.51 (+0.62%)
     

  • GOLD

    2,406.70
    +8.70 (+0.36%)
     

  • Bitcoin AUD

    100,013.41
    +3,442.02 (+3.56%)
     

  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     

  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     

  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

U.S. Specialty Generics Market Growth Opportunities and Forecasts 2021: 10% CAGR Forecast During 2021 to 2026

Research and Markets
·3-min read

Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The United States specialty generics market reached a value of US$ 21 Billion in 2020. Looking forward, the market is forecast to grow at a CAGR of around 10% during 2021-2026.

Specialty generics are economical compared to specialty drugs as they don't need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers.

Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

The leading players in the US specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:

  • How has the US specialty generics market performed so far and how will it perform in the coming years?

  • What is the breakup of the US specialty generics market based on the route of administration?

  • What has been the impact of COVID-19 on the US specialty generics market?

  • What is the breakup of the US specialty generics market based on the therapeutic application?

  • What is the breakup of the US specialty generics market based on the distribution channel?

  • What are the various stages in the value chain of the US specialty generics industry?

  • What are the key driving factors and challenges in the US specialty generics market?

  • What is the structure of the US specialty generics industry and who are the key players?

  • What is the degree of competition in the US specialty generics market?

Key Topics Covered:

  • Executive Summary

  • Global Specialty Generics Market: Introduction

  • Why are Specialty Generics So Lucrative?

  • Global Specialty Generics Market

  • US Specialty Generics Market

  • Market Breakup by Route of Administration

  • Market Breakup by Therapeutic Application

  • Market Breakup by Distribution Channel

  • Competitive Landscape

ADVERTISEMENT


For more information about this report visit https://www.researchandmarkets.com/r/br2uh9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900